Gene · 4900
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Diagnostic Value of Cerebrospinal Fluid Neurogranin in Neurodegenerative Diseases. | Int J Mol Sci | 2024 | 39769345 | PubTator, text mining | PubMed |
| Inflammatory Response of THP1 and U937 Cells: The RNAseq Approach. | Cells | 2024 | 39768153 | PubTator, text mining | PubMed |
| Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease. | Alzheimers Res Ther | 2024 | 39716329 | PubTator, text mining | PubMed |
| CSF synaptic biomarkers and cognitive impairment in multiple sclerosis. | J Neurol | 2024 | 39708160 | PubTator, text mining | PubMed |
| CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds. | Clin Proteomics | 2024 | 39668376 | PubTator, text mining | PubMed |
| Different Proteins as Biomarkers for Sac Shrinkage After Endovascular Aortic Repair of Abdominal Aortic Aneurysms. | J Cardiovasc Dev Dis | 2024 | 39590217 | PubTator, text mining | PubMed |
| Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at 18F-SynVesT-1 Brain PET Imaging. | Radiology | 2024 | 39560478 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer's Disease with Different Rate of Progression (RoP): A Preliminary Study. | Brain Sci | 2024 | 39451975 | PubTator, text mining | PubMed |
| Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease. | Brain Commun | 2024 | 39440304 | PubTator, text mining | PubMed |
| Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease. | Mol Neurodegener | 2024 | 39380095 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis reveals the protective role of S14G-humanin in septic acute kidney injury using 4D-label-free and PRM Approaches. | Biochem Biophys Res Commun | 2024 | 39332154 | PubTator, text mining | PubMed |
| Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline. | Neurology | 2024 | 39303184 | PubTator, text mining | PubMed |
| CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis. | Alzheimers Res Ther | 2024 | 39242539 | PubTator, text mining | PubMed |
| Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: an update of the literature. | Expert Rev Neurother | 2024 | 39233323 | PubTator, text mining | PubMed |
| Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease. | Alzheimers Dement (N Y) | 2024 | 39131742 | PubTator, text mining | PubMed |
| A genetic and proteomic comparison of key AD biomarkers across tissues. | Alzheimers Dement | 2024 | 39077866 | PubTator, text mining | PubMed |
| KLOTHO KL-VS heterozygosity is associated with diminished age-related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults. | Alzheimers Dement | 2024 | 39030746 | PubTator, text mining | PubMed |
| Neurogranin as a biomarker in differentiating traumatic brain injury: A systematic review and meta-analysis. | Am J Emerg Med | 2024 | 39030111 | PubTator, text mining | PubMed |
| Exploring the effect of APOE ε4 on biomarkers of neurodegeneration in Alzheimer's disease. | Clin Chim Acta | 2024 | 39025198 | PubTator, text mining | PubMed |
| CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease. | Alzheimers Dement | 2024 | 38970402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4900/papers?page=7